The FDA’s Orthopedic & Rehabilitation devices panel detailed its schedule for a 1-day meeting taking place in April of next year, during which the committee will discuss risk classification for shortwave diathermy devices.
The FDA in July initially proposed changing the classification of shortwave diathermy devices to require premarket approval.
Sign up to get our free newsletters delivered right to your inbox.
[sead]